
TPCera
Company description
See translation
TPCera develops a new type of immunomodulatory compound that shifts the immune system from an inflammatory state into an anti-inflammatory one. The company is focused on shifting macrophages from M1 to M2, which has the potential to modulate autoimmune d...
HS code: {{pas.hsCode | limitTo: 23}}
Commercial information
Affiliations:
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us